ONLINE CONSULTATION
Transforming Women’s Reproductive Health with Early Cancer Detection
Globally, millions of women are affected by conditions such as Polycystic Ovarian Syndrome (PCOS) , Endometriosis, fibroids, and Human Papillomavirus (HPV), which increase their risk of developing Cervical, Endometrial and Ovarian cancers.
Our non-invasive, self-collected tests use advanced epigenetic analysis to detect early cancer risk. Samples can be easily collected at home and sent directly to our laboratory for evaluation.
Aura-C
Cervical Cancer Early Detection
Cervical Cancer Early Detection Kit
PAX1 And JAM3 Dual-Gene Methylation Technology
Non-invasive screening of Cervical cancer through Cervical Exfoliated Cells
Aura-E
Endometrial Cancer Early Detection
Endometrial Cancer Early Detection Kit
CDO1 and CELF4 Dual-Gene Methylation Technology
Non-invasive screening For endometrial cancer Through Cervical Exfoliated Cells.
Aura-O
Ovarian Cancer Early Detection
Ovarian Cancer Early Detection Kit
CDO1 and HOXA9 Dual-Gene Methylation Technology
Non-invasive screening of ovarian cancer through a simple blood simple blood test.
What is Precision
Immuno-Oncology
Precision immuno-oncology is a specialized cancer treatment that uses the immune system to target and destroy cancer cells with high specificity. It employs advanced methods to analyze a patient’s genetics, immune profile, and tumor biology, enabling personalized therapy.
OncoAdvisor™
Your AI Companion in Precision Oncology
Integrates multi-omics intelligence with clinical decision-making to deliver personalized therapy guidance for
every cancer patient.
